EGFR and diffuse intrinsic pontine glioma: Macy et al. evaluated the efficacy and safety of cetuximab, anti-EGFR humanized with concurrent radiation therapy followed by cetuximab and irinotecan, a topoisomerase I inhibitor, among patients with newly diagnosed DIPG [25].